ADAURA Trial; Early Stage Non–Small Cell Lung Cancer

0 Views
administrator
administrator
07/14/23

Joshua Bauml, MD, reviews the phase 3 ADAURA trial for adjuvant osimertinib for early stage EGFR-positive non–small cell lung cancer.

Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next